Protagenic Therapeutics, Inc.\new
PTIXOTCCIK 1022899HealthcareFiscal year ends Mar 31
Reports and events: 257 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2011:26 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-039410 |
| 2026-08-1916:28 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-039221 |
| 2026-08-1415:19 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001493152-26-038255 |
| 2026-04-0719:13 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-015365 |
| 2026-03-0907:46 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001493152-26-009301 |
| 2026-03-0321:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-008605 |
| 2026-02-2420:49 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-007800 |
| 2026-01-0507:45 ET | 8-K | 3.01 Delisting notice | 0001493152-26-000263 |
| 2025-12-0516:52 ET | DEF 14A | Proxy statementPeriod 2025-12-05 | 0001493152-25-026414 |
| 2025-11-2617:26 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-025201 |
| 2025-11-2616:18 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025159 |
| 2025-11-0516:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-020881 |
| 2025-10-3117:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-020444 |
| 2025-09-1712:21 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-25-013851 |
| 2025-08-2818:28 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001641172-25-025737 |
| 2025-08-2217:28 ET | 8-K | 3.01 Delisting notice; 4.01 Change of auditor; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-025274 |
| 2025-08-1317:16 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events | 0001641172-25-023588 |
| 2025-07-3016:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-021552 |
| 2025-07-2412:39 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-020802 |
| 2025-06-2717:30 ET | 8-K | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001641172-25-016979 |
| 2025-05-2109:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-011878 |
| 2025-05-2011:48 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-011633 |
| 2025-05-1908:19 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-011387 |
| 2025-05-1315:22 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009923 |
| 2025-05-0506:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-008455 |
| 2025-04-2916:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-006649 |
| 2025-04-1813:39 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-005368 |
| 2025-03-3114:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-001600 |
| 2025-03-1017:39 ET | DEF 14A | Proxy statementPeriod 2025-03-07 | 0001493152-25-009597 |
| 2025-02-2416:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-008040 |
| 2025-02-2418:20 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-007942 |
| 2025-01-2916:01 ET | 8-K | 3.01 Delisting notice | 0001493152-25-004143 |
| 2025-01-1618:51 ET | 8-K | 3.01 Delisting notice | 0001493152-25-002448 |
| 2025-01-1006:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-001516 |
| 2025-01-0317:03 ET | DEF 14A | Proxy statementPeriod 2025-01-03 | 0001493152-25-000288 |
| 2024-12-2006:12 ET | S-1 | Registration statement | 0001493152-24-050846 |
| 2024-12-0307:20 ET | 8-K | 8.01 Other events | 0001493152-24-048431 |
| 2024-11-2216:12 ET | 8-K | 3.01 Delisting notice | 0001493152-24-047376 |
| 2024-11-1416:22 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045913 |
| 2024-11-0507:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-043615 |
| 2024-10-3021:52 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-042964 |
| 2024-09-1821:54 ET | 8-K | 8.01 Other events | 0001493152-24-036925 |
| 2024-08-1416:59 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-032349 |
| 2024-07-2617:30 ET | 8-K | 3.01 Delisting notice | 0001493152-24-029295 |
| 2024-05-2416:36 ET | 8-K | 3.01 Delisting notice | 0001493152-24-021383 |
| 2024-05-2209:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-020973 |
| 2024-05-1516:33 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019933 |
| 2024-05-1406:04 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001493152-24-019018 |
| 2024-04-2420:47 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001493152-24-015739 |
| 2024-04-0116:00 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-012333 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.